Partial Trisomy 16p (16p12.2→pter) and Partial Monosomy 22q (22q13.31 →qter) Presenting With Fetal Ascites and Ventriculomegaly: Prenatal Diagnosis and Array Comparative Genomic Hybridization Characterization  by Chen, Chih-Ping et al.
Taiwan J Obstet Gynecol • December 2010 • Vol 49 • No 4
■ CASE REPORT ■
506
Introduction
Partial trisomy 16p is a rare clinical recognizable syn-
drome characterized by mental retardation, growth
retardation, craniofacial abnormalities, abnormally
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SUMMARY
Objective: To present prenatal diagnosis and array comparative genomic hybridization (aCGH) characterization
of partial trisomy 16p (16p12.2pter) and partial monosomy 22q (22q13.31qter) presenting with fetal
ascites and ventriculomegaly in the second trimester.
Case Report: A 31-year-old woman, gravida 2, para 1, was referred to the hospital at 20 weeks of gestation
because of fetal ascites. Amniocentesis revealed a derivative chromosome 22. Subsequent parental karyotyping
revealed that the father carried a balanced reciprocal translocation between 16p12 and 22q13. Bacterial artificial
chromosome-based aCGH using amniocyte DNA demonstrated partial trisomy 16p and partial monosomy 22q
[arr cgh 16p13.3p12.2 (CTD-3077J14RP11-650D5)×3, 22q13.31q13.33 (RP1-111J24CTD-3035C16)×1].
Oligonucleotide-based aCGH showed a 20.9-Mb duplication of distal 16p and an approximate 3.7-Mb deletion
of distal 22q. Level II ultrasound revealed fetal ascites and ventriculomegaly. The pregnancy was terminated and
a malformed male fetus was delivered with craniofacial dysmorphism and abnormalities of the digits. The fetal
karyotype was 46,XY,der(22)t(16;22)(p12.2;q13.31)pat. The paternal karyotype was 46,XY,t(16;22)(p12.2;q13.31).
Conclusion: Partial trisomy 16p can be associated with fetal ascites and ventriculomegaly in the second trimester.
Prenatal sonographic detection of fetal ascites in association with ventriculomegaly should alert chromosomal
abnormalities and prompt cytogenetic investigation, which may lead to the identification of an unexpected
parental translocation involving chromosomal segments associated with cerebral and vascular abnormalities.
[Taiwan J Obstet Gynecol 2010;49(4):506–512]
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placed thumbs, finger tapering, simian crease, club
hand/foot, hammer toes, urogenital abnormalities, car-
diac anomalies, respiratory distress, pulmonary vascu-
lar diseases and other vascular anomalies [1–11]. The
22q13.3 deletion syndrome or Phelan-McDermid syn-
drome (OMIM 606232) is characterized by large or
unusual ears, relatively large hands, full brow, dolicho-
cephaly, ptosis, full cheeks, a bulbous nose, a pointed
chin, autistic behavior, neonatal hypotonia, global dev-
elopmental delay, normal or accelerated growth and
absent to severely delayed speech [12–16]. A concomi-
tant occurrence of partial trisomy 16p and 22q13.3
deletion is unusual. We previously described the appli-
cation of array comparative genomic hybridization
(aCGH) in prenatal diagnosis of aneuploidy [17,18].
Here, we report prenatal diagnosis and aCGH charac-
terization of partial trisomy 16p (16p12.2pter) and
partial monosomy 22q (22q13.31qter) in a fetus
associated with fetal ascites and ventriculomegaly.
Case Report
A 31-year-old woman, gravida 2, para 1, was referred
to the hospital at 20 weeks of gestation because of
fetal ascites which had developed 2 weeks prior to
referral. She had a 5-year-old, healthy daughter. The
woman reported no teratogenic medications, recent
viral infections, diabetes mellitus or hypertension. The
maternal blood group was O, Rh-positive and the
maternal syphilis screen was negative but thalassemia
screen was positive. The paternal thalassemia screen
was negative. Maternal rubella IgG levels were consistent
with past history of a childhood infection of rubella.
The parents were non-consanguineous and healthy and
there was no family history of congenital malformations.
Prenatal sonography at 20 gestational weeks revealed
a male fetus with fetal biometry equivalent to 20 weeks,
a normal amount of amniotic fluid and fetal ascites.
The internal organs were unremarkable. Amniocente-
sis revealed a derivative chromosome 22, or der(22)
(Figure 1). Subsequent parental karyotyping revealed
that the father carried a balanced reciprocal transloca-
tion between 16p12 and 22q13 (Figure 2). The karyo-
type of the mother and her daughter were normal.
Bacterial artificial chromosome-based aCGH of amnio-
cyte DNA using CMDX bacterial artificial chromosome-
based aCGH CA3000 chips (CMDX, Irvine, CA, USA)
demonstrated partial trisomy 16p and partial monosomy
22q [arr cgh 16p13.3p12.2 (CTD-3077J14RP11-
650D5)×3, 22q13.31q13.33 (RP1-111J24CTD-
3035C16)×1] (Figure 3). Oligonucleotide-based aCGH
using Oligo HD Scan (CMDX, Irvine, CA, USA) showed
a 20.9-Mb duplication of distal 16p and an approxi-
mate 3.7-Mb deletion of distal 22q (Figure 4). Level II
ultrasound revealed fetal ascites and ventriculomegaly
(Figure 5). The pregnancy was terminated at 22 gesta-
tional weeks. A 436-g male fetus was delivered with dys-
morphic features including a round face, hypertelorism,
prominent glabella, a bulbous nose, a depressed nasal
bridge, full cheeks, anteverted nares, a long philtrum,
thin lips, micrognathia, low-set ears, a short neck, finger
tapering, malposition of the toes, flexion-deformity of
the fingers, bilateral proximally inserted thumbs, a
bilateral simian crease, a gap between the first and the
second toes, and overlapping fingers (Figures 6 and 7).
The external genitalia and anus were normal. Molecular
analysis revealed negative findings for parvovirus B19,
Figure 1. G-banded karyotype of the fetus shows a derivative chromosome 22, or der(22). The karyotype is 46,XY,der(22)
t(16;22)(p12.2;q13.31)pat. The arrows indicate the breakpoints on normal chromosomes.
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cytomegalovirus, toxoplasma and herpes simplex virus
in the cord blood. The karyotype of the father was
46,XY,t(16;22)(p12.2;q13.31). The karyotype of the
fetus was 46,XY,der(22)t(16;22)(p12.2;q13.31)pat.
Discussion
The present case manifested characteristic craniofacial
and limb abnormalities associated with partial trisomy
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Figure 2. G-banded karyotype of the father shows a der(16) and a der(22). The karyotype is 46,XY,t(16;22)(p12.2;q13.31).
The arrows indicate the breakpoints on normal chromosomes.
Figure 3. Bacterial artificial chromosome-based array comparative genomic hybridization shows partial trisomy 16p [arr cgh
16p13.3p12.2 (CTD-3077J14RP11-605D5)×3] and partial monosomy 22q [arr cgh 22q13.31q13.33 (RP1-111J24
CTD-3035C16)×1].
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Figure 6. (A) and (B) Craniofacial appearance of the proband shows a round face, hypertelorism, prominent glabella, a bulbous
nose, a depressed nasal bridge, full cheeks, anteverted nares, a long philtrum, thin lips, low-set ears and micrognathia.
Figure 7. (A) Flexion-deformity of the fingers, finger tapering, simian crease and proximally inserted thumbs of the hands. 
(B) Malposition of the toes and a gap between the first and the second toes.
A B0
5
10 1
Figure 5. (A) Prenatal ultrasound at 20 gestational weeks shows fetal ascites. (B) Prenatal ultrasound at 22 gestational weeks
shows ventriculomegaly.
16p and 22q13.3 deletion syndrome. This case had
chromosome 16p duplication encompassing the critical
region of 16p13.1–p13.3 and chromosome 22q deletion
encompassing the critical region of 22q13.3. Previous
studies have shown that the critical region of partial
trisomy 16p is located within 16p13.1-p13.3, and the
phenotypic severity does not correlate to the size of 
the duplicated segment [8]. Haploinsufficiency of the
SHANK3 gene (OMIM 606230) on 22q13.3 has been
shown to be a major causative factor in the neurological
symptoms of 22q13.3 deletion syndrome, including
neonatal hypotonia, developmental delay, absent to
severely delayed speech and autistic behavior [19]. The
SHANK3 gene encodes proline-rich synapse-associated
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protein 2, which is a structural protein of post-synaptic
density.
The present case was associated with fetal ascites.
Fetal ascites and hydrops fetalis have been described in
fetuses with partial trisomy 16p. Chen et al [6] reported
bilateral renal agenesis, oligohydramnios and fetal ascites
in a fetus with partial trisomy 16p (16p13.2pter)
and partial trisomy 13q (13q12.3qter). Martin et al
[8] reported non-immune hydrops fetalis and cystic
hygroma in a fetus with an approximate 10-Mb terminal
16p duplication. Digilio et al [11] reported the associa-
tion of partial trisomy 16p (16p13.1-p13.3) with pulmo-
nary vascular disease, pulmonary hypertension, portal
cavernoma, vascular ring and vascular disruption, and
suggested that this critical region is related to vascular
abnormalities.
The present case was also associated with ventriculo-
megaly. In a review of 11 patients with microduplication
of the subtelomeric region of chromosome 16p, Digilio
et al [11] found 38% (3/8) of the patients had corpus
callosum hypoplasia, and 55% (6/11) of the patients
had microcephaly. Digilio et al [11] reported a female
infant with a 12-Mb duplication of 16p13.3p13.13,
portal hypertension, a portal vein cavernoma with
esophageal varices and corpus callosum hypoplasia.
Martin et al [8] reported a female infant with severe
classical lissencephaly, mild hypogenesis of the ros-
trum and splenium of the corpus callosum and moder-
ate enlargement of the lateral ventricles and cavum
septi pellucidi and an approximate 3.5–4-Mb terminal
16p duplication. Martin et al [8] also reported a female
infant with sagittal craniosynostosis, corpus callosum
hypoplasia, arachnoid cyst, seizures, mental retarda-
tion, a behavior disorder and a 10-Mb terminal 16p
duplication. The present case additionally provides
evidence that partial trisomy 16p can present fetal
ascites and ventriculomegaly in the second trimester.
In conclusion, prenatal sonographic detection of
fetal ascites in association with ventriculomegaly should
be an indicator for chromosomal abnormalities and
prompt cytogenetic investigation, which may lead to the
identification of an unexpected parental translocation
involving chromosomal segments associated with cerebral
and vascular abnormalities. The information acquired
through perinatal studies is helpful for both genetic
counseling and investigation of subsequent pregnancies.
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